Showing results (231-240 of 356) with videos related to

Sort By:
Pageof 36
Colloids and Surfaces. B, Biointerfaces|October 29, 2017
Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubblesGuankui Wang, Halli Benasutti, Jessica F Jones, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
Cureus|August 28, 2023
Intravenous Administration of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC) for Acute Respiratory Distress Syndrome Due to COVID-19 InfectionJesus A Perez, Juan J Parcero Valdes, Ruben Corral Moreno, et al.
Neuro-Oncology Advances|July 13, 2022
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating FieldsManjari Pandey, Joanne Xiu, Sandeep Mittal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 PatientsMaria Schwaederle, Hatim Husain, Paul T Fanta, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2016
Cognitive dysfunction in patients with brain metastases: influences on caregiver resilience and copingMarlon Garzo Saria, Natasia Courchesne, Lorraine Evangelista, et al.
World Neurosurgery|June 22, 2019
Strategy and Technique of Endonasal Endoscopic Bony Decompression and Selective Tumor Removal in Symptomatic Skull Base Meningiomas of the Cavernous Sinus and Meckel's CaveWalavan Sivakumar, Garni Barkhoudarian, Bjorn M Lobo, et al.
Archives of Neurology|March 10, 2010
Morphological characteristics of brain tumors causing seizuresJong Woo Lee, Patrick Y Wen, Shelley Hurwitz, et al.
Archives of Pathology & Laboratory Medicine|May 26, 2024
A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal MetastasesNathan T Sweed, Hao-Ching Hsiao, Barbara Blouw, et al.
The Oncologist|October 16, 2025
Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 resultsIben Spanggaard, Marc Matrana, Caio Rocha Lima, et al.
Pageof 36